Dagmar Wilsmann-Theis

Demonstration of improvement in moderate to se-vere chronic PPP after guselkumab administration Evaluation of efficacy and safety of guselkumab application in patients with moderate to severe PPP Determination of improvement of quality of life due to guselkumab administration in patients with moderate to severe PPP Demonstration of improvement in moderate to severe chronic PPP after guselkumab administration

This Trial contains a sub-study with the following related objectives Exploration of the ...